title: Deal watch: Pfizer deal for selectin inhibitor highlights potential of glycomimetic drugs.
mesh_terms: D032701:Biomimetics / Q000639:trends*; D002241:Carbohydrates / Q000138:chemical synthesis*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015195:Drug Design; D055808:Drug Discovery / Q000639:trends*; D004345:Drug Industry / Q000639:trends; D006017:Glycolipids / Q000627:therapeutic use*; D006801:Humans; D019087:Selectins / Q000378:metabolism*
chemical_list: D002241:Carbohydrates; D006017:Glycolipids; D019087:Selectins; C553182:rivipansel